CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 397 enrolled
Drug / intervention
Calcium Chloride +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04153435
NCT04153435Phase 2Completed

Calcium for Out-of-Hospital Cardiac Arrest - A Randomized, Double-Blind, Placebo-Controlled Trial

Lars Wiuff Andersen·interventional·Posted Nov 6, 2019·Updated Jul 25, 2022

In Brief

A Phase 2 clinical trial evaluating Calcium Chloride and Sodium chloride 0.9% for Heart Arrest, Out-Of-Hospital. Completed, enrolled 397 participants across 1 site.

Detailed Summary

This is an investigator-initiated, multicenter, randomized, placebo-controlled, parallel group, double-blind, superiority trial of calcium during adult out-of-hospital cardiac arrest. 430 adult patients with out-of-hospital cardiac arrest receiving at least one dose of adrenaline will be enrolled. The primary outcome is sustained return of spontaneous circulation and key secondary outcomes include survival at 30 days and survival at 30 days with a favorable neurological outcome.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesDenmark

Timeline

Phase 2CompletedFinished
2020202120222023202420252026
First PostedNov 6, 2019
Enrollment StartJan 20, 2020
Primary CompletionApr 15, 2021
Study CompletionApr 15, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 6.7 years ago

Interventions

Calcium Chloridedrug

Calcium chloride 5 mmol

Sodium chloride 0.9%drug

Placebo